Clinical Trials Directory

Trials / Completed

CompletedNCT04822389

Telerehabilitation and Lymphoma Patients

Effect of the Physical Exercise Training Using Telerehabilitation Among Lymphoma Patients: A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Brno University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to examine the feasibility and effect of a home-based short-term telerehabilitation exercise intervention using heart rate monitor and internet platform in patients with lymphoma.

Detailed description

Fifteen lymphoma cancer patients post-treatment (except adjuvant treatment) will be enrolled in the study. Cardiorespiratory fitness (peak oxygen consumption), adverse events, body composition and adherence to exercise prescription will be evaluated at baseline, 12-week, and year after enrollment.

Conditions

Interventions

TypeNameDescription
DEVICETelerehablitation using heart rate monitorEligible participants will undergo 12 weeks of physical exercise using a heart rate monitor and internet platform at home. The participants will regularly (minimum once per week) upload the exercise data from the heart rate monitor into the internet platform. An exercise telerehabilitation session consists of the warm-up phase, aerobic phase (30 - 50 minutes gradually increasing exercise duration; heart rate zone based on baseline cardiopulmonary exercise test) and cool-down phase. The exercise training period is set to 3 times a week for 12 weeks. Study participants will receive user guides developed by research team with detailed instructions regarding equipment set-up, training protocol, and contact information. Also, participants will receive weekly phone calls from week 0 to week 12 to monitor adverse events, encourage compliance and adherence to the study protocol, address any subject questions or concerns, and collect information regarding participants' current symptomatology.

Timeline

Start date
2021-04-01
Primary completion
2022-04-26
Completion
2022-05-31
First posted
2021-03-30
Last updated
2022-07-20

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT04822389. Inclusion in this directory is not an endorsement.